Boston Trust Walden’s CR Bard Inc. BCR Stock Holding History
Bought
Maintained
Sold
Other funds holding BCR
GCIA
MSE
GF
AGM
CWM
BS
QCMA
AAF
Boston Trust Walden's BCR Position: Q4 2017 in Review
Boston Trust Walden sold out of CR Bard Inc. (BCR) in Q4 2017, closing a stake of 193,872 shares — an estimated $62.1M sold.
Boston Trust Walden first reported a position in BCR in Q2 2013 and held it in 18 quarters. The position peaked at $85.2M in Q1 2017. 111 funds tracked by Wall St. Rank hold BCR as of Q4 2017.
- Boston Trust Walden reported no remaining CR Bard Inc. position as of Q4 2017 after selling out during the quarter.
- Boston Trust Walden sold 193,872 CR Bard Inc. shares in Q4 2017, an estimated $62.1M.
- Boston Trust Walden first reported a position in CR Bard Inc. in Q2 2013 and held it in 18 quarters.
- Boston Trust Walden's CR Bard Inc. position peaked at $85.2M in Q1 2017.
- 111 funds tracked by Wall St. Rank held CR Bard Inc. as of Q4 2017.
Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.